Suppr超能文献

普通肿瘤患者皮下输注端口的并发症

Complications of subcutaneous infusion port in the general oncology population.

作者信息

Ballarini C, Intra M, Pisani Ceretti A, Cordovana A, Pagani M, Farina G, Perrone S, Tomirotti M, Scanni A, Spina G P

机构信息

2a Divisione di Chirurgia Generale, Sezione di Chirurgia Vascolare, Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milano, Italia.

出版信息

Oncology. 1999;56(2):97-102. doi: 10.1159/000011947.

Abstract

Subcutaneous infusion ports (SIPs) represent a valid method for long-term chemotherapy. The SIPs have several advantages over other methods of venous access: they are easy to implant under local anaesthesia, have less discomfort for the patients, allow low costs, can be implanted in day hospital, and can be managed ambulatorily. However, SIPs have delayed complications, frequently related to clinical conditions of the neoplastic patients, and immediate complications, often due to the placement technique. From March 1992 to March 1997 we placed, under local anaesthesia and under fluoroscopic control, 102 SIPs in 99 general oncology patients for long-term chemotherapy (88% solid, 12% haematological tumours). The percutaneous venous access devices were in the subclavian vein in 96% of the cases and in the internal jugular vein in 4% of them. Immediate complications were: 1 haemopneumothorax, which required thoracic aspirations and two blood transfusions, 1 loop of the tunneled part of the catheter without alterations in SIP function, and 1 left jugular thrombosis in a patient with subclavian veins already thrombosed. The venous access was in the subclavian vein in the first 2 cases, and it was not necessary to suspend the therapeutic program. In the third instance, implanted in jugular vein, it was necessary to remove the SIP. Delayed complications were: 1 necrosis of the skin over the port, 1 infection of subcutaneous pocket, 2 infections of the system, 1 catheter deconnection, and 3 catheter ruptures with embolization of the catheter tip. The SIPs were removed in all cases but 1 in whom infection was successfully treated by appropriate antibiotic therapy. Embolization of the catheter required removal from the pulmonary artery under fluoroscopic guidance in the cardiac catheterization laboratory. In conclusion, infection and thrombosis are the two major complications of SIP in general oncology patients. In these cases it is not necessary to remove systematically the system, but a correct therapy (antibiotic, fibrinolytic agents) can be utilized with good results. The catheter rupture is often due to the wear over the costoclavicular angle. The interventional radiology is the method of choice in the treatment of the catheter embolization by rupture or dislocation. The experience of the surgical and nursing staff is probably the most important factor in decreasing the total rate of complications.

摘要

皮下输注端口(SIPs)是长期化疗的一种有效方法。与其他静脉通路方法相比,SIPs具有几个优点:它们易于在局部麻醉下植入,给患者带来的不适较少,成本较低,可以在日间医院植入,并且可以门诊管理。然而,SIPs存在延迟并发症,通常与肿瘤患者的临床状况有关,以及即刻并发症,往往归因于放置技术。从1992年3月至1997年3月,我们在局部麻醉和透视控制下,为99例普通肿瘤患者植入了102个SIPs用于长期化疗(实体瘤占88%,血液系统肿瘤占12%)。经皮静脉通路装置96%位于锁骨下静脉,4%位于颈内静脉。即刻并发症有:1例血气胸,需要胸腔穿刺抽吸和两次输血;1例导管隧道部分成袢,但SIP功能无改变;1例锁骨下静脉已血栓形成的患者发生左侧颈静脉血栓形成。前2例静脉通路位于锁骨下静脉,无需暂停治疗方案。第三例植入颈静脉,需要移除SIP。延迟并发症有:1例端口上方皮肤坏死;1例皮下囊袋感染;2例系统感染;1例导管断开;3例导管破裂伴导管尖端栓塞。除1例感染经适当抗生素治疗成功外,所有病例的SIPs均被移除。导管栓塞需要在心脏导管实验室透视引导下从肺动脉取出。总之,感染和血栓形成是普通肿瘤患者SIPs的两大主要并发症。在这些情况下,无需系统性地移除该系统,但可以采用正确的治疗方法(抗生素、纤溶药物),效果良好。导管破裂常因在肋锁角处磨损所致。介入放射学是治疗导管破裂或脱位所致导管栓塞的首选方法。手术和护理人员的经验可能是降低并发症总发生率的最重要因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验